FeesSafety
Pluang+
Home/News Feed/Rosen Law investigates TransMedics Group for possible breaches of fiduciary duties.
TMDX
$71.84
-$0.56 -0.77%

Rosen Law investigates TransMedics Group for possible breaches of fiduciary duties.

Market News
31 Aug 2026
PRNewsWire
View Source
Bearish
Rosen Law investigates TransMedics Group for possible breaches of fiduciary duties.

Rosen Law Firm is investigating potential breaches of fiduciary duties by the directors and officers of TransMedics Group, Inc. This legal action could impact shareholders and the company's governance. Investors holding TransMedics shares are encouraged to seek more information and consider legal counsel. The firm has a strong track record in securities class actions and shareholder litigation, signaling serious scrutiny of TransMedics' management practices.

More News (TMDX)

TransMedics to report Q3 2026 financial results on Nov 5 with a live conference call.

TransMedics to report Q3 2026 financial results on Nov 5 with a live conference call.

TransMedics Group, a leader in organ transplant technology, will announce its third quarter 2026 financial results after market close on November 5, 2026. The company will host a conference call for investors to discuss the results, accessible via ph...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App